药物对比
Alogliptin vs Dulaglutide
Alogliptin vs Dulaglutide治疗2型糖尿病：口服DPP-4抑制剂vs每周一次GLP-1。比较A1C降幅、减重效果、心血管获益、注射vs口服药片及黑框警告风险。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients on a DPP-4 inhibitor seeking greater A1C reduction, weight loss or cardiovascular protection with a GLP-1 agonist.
结论
Dulaglutide often outperforms alogliptin on efficacy and CV outcomes but requires weekly injections, while alogliptin offers oral convenience; neither is universally superior.
全部药物对比